deCODE to Integrate New Genetic Risk Factor for Type 2 Diabetes Into Its deCODEme(TM)
 

deCODE genetics (NASDAQ:DCGN) today announced the discovery by an international consortium of scientists from deCODE and major European and US academic institutions of a single letter variation in the human genome (SNP) that is associated with increased fasting glucose levels and risk of type 2 diabetes (T2D).

More...